These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38055156)

  • 41. Sweeteners, dyes, and other excipients in vitamin and mineral preparations.
    Kumar A; Aitas AT; Hunter AG; Beaman DC
    Clin Pediatr (Phila); 1996 Sep; 35(9):443-50. PubMed ID: 8877241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services.
    Geier DA; Kern JK; Homme KG; Geier MR
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29329213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anaphylaxis to Excipients in Current Clinical Practice: Evaluation and Management.
    Bruusgaard-Mouritsen MA; Nasser S; Garvey LH; Krantz MS; Stone CA
    Immunol Allergy Clin North Am; 2022 May; 42(2):239-267. PubMed ID: 35469617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disposition of polyoxyethylated excipients in humans: implications for drug safety and formulation approaches.
    Ten Tije AJ; Loos WJ; Verweij J; Baker SD; Dinh K; Figg WD; Sparreboom A
    Clin Pharmacol Ther; 2003 Nov; 74(5):509-10. PubMed ID: 14586392
    [No Abstract]   [Full Text] [Related]  

  • 46. Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance.
    Izquierdo-García E; Lázaro-Cebas A; Montero Pastor B; Such Díaz A; Álvaro-Alonso EA; López Guerra L; Escobar-Rodríguez I
    Orphanet J Rare Dis; 2024 Jan; 19(1):12. PubMed ID: 38183105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk assessment of supply chain for pharmaceutical excipients with AHP-fuzzy comprehensive evaluation.
    Li M; Du Y; Wang Q; Sun C; Ling X; Yu B; Tu J; Xiong Y
    Drug Dev Ind Pharm; 2016 Apr; 42(4):676-684. PubMed ID: 26266963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
    Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
    Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Qualitative and quantitative control of pediatric syrups using Nuclear Magnetic Resonance and chemometrics.
    Alves Filho EG; Silva LMA; Araújo NVP; Alves EG; Lião LM; Alcantara GB
    J Pharm Biomed Anal; 2018 May; 153():29-36. PubMed ID: 29459233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and evaluation of bromocryptine mesylate-polydimethylsiloxane matrices.
    Acartürk F; Altuğ N
    Pharmazie; 2000 Sep; 55(9):668-71. PubMed ID: 11031770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse drug reactions from birth to early childhood.
    Gupta A; Waldhauser LK
    Pediatr Clin North Am; 1997 Feb; 44(1):79-92. PubMed ID: 9057785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential cross-reactivity of polysorbate 80 and cremophor: A case report.
    Bibera MAT; Lo KMK; Steele A
    J Oncol Pharm Pract; 2020 Jul; 26(5):1279-1281. PubMed ID: 31955702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An assessment of the ocular safety of inactive excipients following sub-tenon injection in rabbits.
    Younis HS; Shawer M; Palacio K; Gukasyan HJ; Stevens GJ; Evering W
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):206-16. PubMed ID: 18345993
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety issues with ethanol as an excipient in drugs intended for pediatric use.
    Zuccotti GV; Fabiano V
    Expert Opin Drug Saf; 2011 Jul; 10(4):499-502. PubMed ID: 21417862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer.
    Tagawa N; Sugiyama E; Tajima M; Sasaki Y; Nakamura S; Okuyama H; Shimizu H; Sato VH; Sasaki T; Sato H
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):841-849. PubMed ID: 28864856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are Injection Site Reactions in Monoclonal Antibody Therapies Caused by Polysorbate Excipient Degradants?
    Singh SK; Mahler HC; Hartman C; Stark CA
    J Pharm Sci; 2018 Nov; 107(11):2735-2741. PubMed ID: 30055223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients.
    Binson G; Beuzit K; Migeot V; Marco L; Troussier B; Venisse N; Dupuis A
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 31003500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized.
    Stone CA; Liu Y; Relling MV; Krantz MS; Pratt AL; Abreo A; Hemler JA; Phillips EJ
    J Allergy Clin Immunol Pract; 2019; 7(5):1533-1540.e8. PubMed ID: 30557713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The potentially harmful excipients in prescribed medications in a Neonatal Intensive Care Unit in Kosovo and available safer alternatives.
    Koshi B; Grapci AD; Nebija D; Selmani PB; Morina R; Crcarevska MS; Dodov MG; Raichki RS
    Turk J Pediatr; 2022; 64(1):49-58. PubMed ID: 35286030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the Hemodynamic Effects of Intravenous Amiodarone Formulations During the Maintenance Phase Infusion.
    Lindquist DE; Rowe AS; Heidel E; Fleming T; Yates JR
    Ann Pharmacother; 2015 Dec; 49(12):1317-21. PubMed ID: 26416947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.